Sponsor:
University of Maryland, Baltimore
Code:
NCT06993597
Conditions
Glaucoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Prostaglandin Analogue -Containing IOP-Lowering Therapy
Beta Blocker
Brillouin Microscopy
Brief summary:
Conditions
Glaucoma
Study ID
NCT06993597
Start date
Sep 1, 2025
Status verified date
Aug, 2026
Completion date
Jun, 2027
Anticipated
Primary completion date
Mar, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Arms
Normal Tension Glaucoma
High Tension Glaucoma
Control
Interventions
Prostaglandin Analogue -Containing IOP-Lowering Therapy
Beta Blocker
Brillouin Microscopy
Primary outcome measure
Central contacts
Locations
University of Maryland School of Medicine
Recruiting
Baltimore, Maryland, United States, 21201-1757
Contacts
Principal Investigator:
Osamah Saeedi, MD
Sponsor
University of Maryland, Baltimore
Last update posted
Aug 10, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Maryland, Baltimore on 2026-08-10.